May 12, 2026 08:00AM
Apr 22, 2026 08:02AM
Apr 22, 2026 08:00AM
Mar 6, 2026 08:00AM
Feb 26, 2026 08:01AM
Feb 26, 2026 08:00AM
Nov 12, 2025 08:00AM PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
Oct 24, 2025 11:40AM
Oct 24, 2025 11:39AM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM
Sep 10, 2025 01:45PM
Sep 10, 2025 07:00AM
Sep 10, 2025 07:00AM PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Aug 7, 2025 08:42AM
May 9, 2025 08:00AM
Mar 3, 2025 08:00AM
Nov 7, 2024 08:00AM
Oct 23, 2024 08:00AM
Aug 8, 2024 08:00AM
May 29, 2024 07:04AM PMV Pharmaceuticals (PMVP) and Foundation Medicine Collaborate to Develop Companion Diagnostic for Rezatapopt
May 29, 2024 07:00AM
May 9, 2024 08:00AM
Mar 27, 2024 08:00AM
Mar 18, 2024 04:01PM
Mar 18, 2024 04:01PM
Feb 29, 2024 04:01PM
Jan 18, 2024 04:01PM PMV Pharmaceuticals (PMVP) Announces Prioritization of PC14586 Clinical Development, Cuts 30% Staff
Jan 18, 2024 04:01PM
Jan 5, 2024 04:01PM
Jan 5, 2024 04:01PM
Dec 27, 2023 04:16PM
Nov 9, 2023 08:00AM
Oct 12, 2023 12:32PM
Oct 12, 2023 12:30PM PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation
Oct 11, 2023 12:00PM
Sep 20, 2023 04:05PM
Aug 9, 2023 08:00AM
May 10, 2023 08:00AM
Mar 1, 2023 08:00AM
Nov 8, 2022 08:00AM
Nov 4, 2022 08:02AM PMV Pharmaceuticals (PMVP) Appoints Carol Gallagher to its Board
Nov 4, 2022 08:00AM
Aug 9, 2022 08:00AM
Jul 18, 2022 08:07AM
Jul 18, 2022 08:00AM
Jun 7, 2022 12:00PM
Jun 7, 2022 12:00PM
Nov 12, 2021 07:15AM PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights
Aug 13, 2021 08:00AM

323,584 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All